HEALTH CARE Minnie Baylor-Henry, RPh, JD, has resigned from her position as director, division of drug marketing, advertising, and communications, FDA. She has joined the Pharmaceutical Research Institute, a Johnson & Johnson company. Stepping into her shoes, at least temporarily, is Norman A. Drezin, RPh, JD, who now serves as acting director of the division. He had been deputy director. Tom Abrams has been appointed acting deputy director.
Register to view the full article
Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.
0 comments
Hide comments